Literature DB >> 14560562

Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients.

Neal S Goldstein1, Larry Kestin, Frank Vicini.   

Abstract

All slides from 607 consecutive invasive breast carcinomas from 583 patients were reviewed. Margin distance, composite width of invasive carcinoma, and number of ducts with intraductal carcinoma within the one-half low-power field (LPF) adjacent to the final margin were recorded. Final margin groups were positive (carcinoma at margin), near (< or = 1/2 LPF of margin), and negative (> 1/2 LPF). There were 39 ipsilateral breast failures (IBFs), and 63 patients (10.8%) developed distant metastases (DMs). Decreasing margin distance and increasing amounts of carcinoma near the margin were associated with IBF and DM. The 5-tiered composite factor of margin distance and amount of carcinoma near margin (negative margins, near least amount, near intermediate amount, near greatest amount, and positive margins) resulted in 12-year IBF rates of 9%, 6%, 18%, 24%, and 30%, respectively (P < .001). The composite factor, margin amount of carcinoma near margin, and invasive carcinoma/initial excision specimen dimension ratio were the most precise parameters assessing excision adequacy and, ultimately, IBF risk. The amount of carcinoma near the margin and volume of excised parenchyma related directly to the amount of residual carcinoma in the adjacent breast parenchyma.

Entities:  

Mesh:

Year:  2003        PMID: 14560562     DOI: 10.1309/8941-VDAJ-MKY2-GCLX

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

Review 1.  Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group.

Authors:  Bruno Meduri; Fiorenza De Rose; Carlo Cabula; Isabella Castellano; Lucia Da Ros; Massimo Maria Grassi; Sandra Orrù; Fabio Puglisi; Rubina Manuela Trimboli; Antonella Ciabattoni
Journal:  Med Oncol       Date:  2021-05-10       Impact factor: 3.064

2.  Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation.

Authors:  N J Look Hong; G M Clarke; M J Yaffe; C M B Holloway
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

3.  Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Authors:  Tomofumi Osako; Reiki Nishimura; Yasuyuki Nishiyama; Yasuhiro Okumura; Rumiko Tashima; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  Int J Clin Oncol       Date:  2015-04-09       Impact factor: 3.402

4.  A propensity score-matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer.

Authors:  Francesca Magnoni; Giovanni Corso; Patrick Maisonneuve; Giulia Massari; Luca Alberti; Giulia Castelnovo; Maria Cristina Leonardi; Virgilio Sacchini; Viviana Galimberti; Paolo Veronesi
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-07       Impact factor: 4.553

5.  The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.

Authors:  Nehmat Houssami; Petra Macaskill; M Luke Marinovich; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2014-01-29       Impact factor: 5.344

6.  Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

Authors:  Heather A Jones; Ninja Antonini; Augustinus A M Hart; Johannes L Peterse; Jean-Claude Horiot; Françoise Collin; Philip M Poortmans; S Bing Oei; Laurence Collette; Henk Struikmans; Walter F Van den Bogaert; Alain Fourquet; Jos J Jager; Dominic A X Schinagl; Carla C Wárlám-Rodenhuis; Harry Bartelink
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

Review 7.  Accelerated partial breast irradiation: the case for current use.

Authors:  Martin E Keisch
Journal:  Breast Cancer Res       Date:  2005-04-05       Impact factor: 6.466

8.  A systematic review of clinical outcomes and radiotherapy-associated toxicity in multicatheter accelerated partial breast irradiation.

Authors:  Yang Lv; Lin He; Chao Wang; Lijiu Zhang; Biyuan Zhang; Yuhua Song
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

9.  Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.

Authors:  Fabien Reyal; David Hajage; Alexia Savignoni; Jean-Guillaume Feron; Marc Andrew Bollet; Youlia Kirova; Alain Fourquet; Jean-Yves Pierga; Paul Cottu; Veronique Dieras; Virginie Fourchotte; Fatima Laki; Severine Alran; Bernard Asselain; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Xavier Sastre-Garau
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour.

Authors:  Katie T Huang; Thomas Mikeska; Jason Li; Elena A Takano; Ewan K A Millar; Peter H Graham; Samantha E Boyle; Ian G Campbell; Terence P Speed; Alexander Dobrovic; Stephen B Fox
Journal:  BMC Cancer       Date:  2015-10-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.